Alzheimer's disease

Sage Bionetworks Launches Platform to Crowdsource the Evaluation of Curated Alzheimer’s Disease Genomic Analysis
Fri, 07/20/18 - 09:25 am
Sage Bionetworks
Alzheimer's disease
AAIC event – Biogen and Eisai move to consolidate beta-amyloid lead
EP Vantage
Tue, 07/17/18 - 11:20 pm
Biogen
Eisai
BAN2401
Alzheimer's disease
Are We on the Cusp of a Big Alzheimer's Disease Breakthrough?
Motley Fool
Sat, 07/14/18 - 01:21 pm
Alzheimer's disease
clinical trials
Biogen
drug development
BAN2401
Mylan launches generic drug-delivery patch for dementia patients
Drug Delivery Business News
Mon, 07/9/18 - 11:26 am
Mylan
rivastigmine
generics
Novartis
Exelon
dementia
Alzheimer's disease
Parkinson's Disease
The Biogen Bump Bodes Well for Biotech
Barron's
Sat, 07/7/18 - 04:32 pm
Biogen
Eisai
Alzheimer's disease
BAN2401
Biogen reports positive results with Alzheimer’s drug, reviving hopes for once-failed treatment
Stat
Thu, 07/5/18 - 08:24 pm
BAN2401
Biogen
clinical trials
Alzheimer's disease
New study supports long-dismissed idea: Herpes viruses could play role in Alzheimer’s
Stat
Thu, 06/21/18 - 11:56 am
Alzheimer's disease
Eisai is building a bespoke Cambridge research center with a $100M-plus plan to find new ways to tackle Alzheimer’s
Endpoints
Wed, 06/13/18 - 09:37 am
Eisai
R&D
Cambridge MA
Alzheimer's disease
Eli Lilly and AstraZeneca Drop PhIII Alzheimer's Candidate – BACE Class May Be Done
CP Wire
Tue, 06/12/18 - 09:16 am
Eli Lilly
AstraZeneca
lanabecestat
Alzheimer's disease
BACE inhibitors
Eli Lilly and AstraZeneca Drop PhIII Alzheimer's Candidate – BACE Class May Be Done
Tue, 06/12/18 - 09:02 am
Eli Lilly
AstraZeneca
lanabecestat
Alzheimer's disease
Cognition Therapeutics Receives $6.6M from NIA to Study Elayta Synaptoprotective Mechanism of Action in Alzheimer's
CP Wire
Tue, 05/22/18 - 06:17 pm
Cognition Therapeutics
Elayta
NIH
grants
Alzheimer's disease
Alzheimer’s Disease: Companies Weigh Revised FDA Draft Guidance
RAPS.org
Tue, 05/22/18 - 11:06 am
Alzheimer's disease
FDA
Roche
AstraZeneca
Bioclinica
Eli Lilly
Denali Therapeutics
Cognition Therapeutics Receives $6.6M from NIA to Study Elayta Synaptoprotective Mechanism of Action in Alzheimer's
Tue, 05/22/18 - 06:16 pm
Cognition Therapeutics
Alzheimer's disease
Janssen drops the BACE as Alzheimer’s candidate joins fail list
Fierce Biotech
Fri, 05/18/18 - 12:09 pm
JNJ
Janssen
BACE inhibitors
atabacestat
Alzheimer's disease
EIP Pharma Receives $20.5 Million Series B to Fund Alzheimer's Candidate
CP Wire
Wed, 05/16/18 - 09:13 am
EIP Pharma
Alzheimer's disease
neflamapimod
EIP Pharma Receives $20.5 Million Series B to Fund Alzheimer's Candidate
Wed, 05/16/18 - 07:55 am
EIP Pharma
Alzheimer's disease
neflamapimod
Poised to launch its first marketing effort, Alnylam makes a big leap into CNS diseases and Alzheimer’s
Endpoints
Tue, 05/8/18 - 08:22 pm
Alnylam
RNAi
Alzheimer's disease
Australian and US Scientists Discover New Insights into Dementia and Alzheimer’s
CP Wire
Fri, 05/4/18 - 10:16 am
Alzheimer's disease
dementia
drug development
Australia
Australian and US Scientists Discover New Insights into Dementia and Alzheimer’s
Thu, 05/3/18 - 06:11 pm
Alzheimer's disease
Merck study may signal doom for a broad group of pivotal Alzheimer’s studies
Endpoints
Thu, 05/3/18 - 11:43 am
BACE
Alzheimer's disease
Merck
verubecestat

Pages